Mark A Glickman Insider Trading $ESPR Esperion Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark A Glickman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark A Glickman. Mark A Glickman is SVP, Sales & Marketing in OSCIENT PHARMACEUTICALS CORP ($GENE) and Chief Commercial Officer in POZEN INC /NC ($POZN) and Chief Commercial Officer in Esperion Therapeutics, Inc. ($ESPR) and Chief Commercial Officer in Aralez Pharmaceuticals Inc. ($ARLZ).
Mark A Glickman in Esperion Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark A Glickman: Chief Commercial Officer
Holdings: 25,925 shares
Current Value: $457,836
Latest Transaction: Jan 03 2020
$ESPR Market Capitalization: $454.22M
$ESPR Previous Close: $17.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Mark A Glickman in Esperion Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ESPR, ARLZ, GENE, POZN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 03 2020 | ESPR | Esperion Therapeut ... | Glickman Mark A | Chief Commercial Of ... | Option Exercise | A | 61.34 | 26,625 | 1,633,178 | 26,625 | |
| Jan 03 2020 | ESPR | Esperion Therapeut ... | Glickman Mark A | Chief Commercial Of ... | Grant | A | 0.00 | 5,925 | 0 | 25,925 | 20 K to 25.9 K (+29.63 %) |
Page: 1